Home

Julie D Klapstein

CIK 1518668 · last filed 2026-07-07

Julie D Klapstein is a corporate insider who has filed 46 SEC Form 4 insider transactions across 8 companies since 2011. The most recent filing, for OMDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is +$36.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.27M

Companies

8

Total Filings

46

Lifetime Open-Market Net

$36.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OMDA Director 21,965 $23.67 $519.9K $0 4 2026-07-07
Claritev Corp (MPLN) Delisted Director 24,611 $23.15 $569.7K $0 3 2026-05-01
AMEDISYS INC (AMED) Delisted Director 0 $100.99 $0 -$85.7K 14 2025-08-14
NEXTGEN HEALTHCARE, INC. (NXGN) Delisted Director 70,104 $23.94 $1.68M $0 5 2023-08-23
Oak Street Health, Inc. (OSH) Delisted Director 0 $39.00 $0 $50.0K 6 2023-05-02
Claritev Corp (MPLN.WS) Delisted Director 158,758 $0.00 $476 $72.0K 5 2023-04-28
Annie's, Inc. (BNNY) Delisted Director 3,828 — — $0 3 2014-09-11
SR Director 9,190 $81.97 $753.3K $0 2 2013-11-04

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 OMDA Grant (A) +649 $0 EDGAR
2026-06-18 OMDA Grant (A) +10,882 $0 EDGAR
2026-05-01 Claritev Corp (MPLN) Delisted Grant (A) +8,977 $0 EDGAR
2026-04-07 OMDA Grant (A) +698 $0 EDGAR
2025-08-14 AMEDISYS INC (AMED) Delisted Disp (D) −16,031 $0 EDGAR
2025-06-09 OMDA Grant (A) +9,736 $0 EDGAR
2025-05-06 AMEDISYS INC (AMED) Delisted Grant (A) +1,690 $0 EDGAR
2025-05-02 Claritev Corp (MPLN) Delisted Grant (A) +7,356 $0 EDGAR
2024-05-07 AMEDISYS INC (AMED) Delisted Grant (A) +1,678 $0 EDGAR
2024-04-26 Claritev Corp (MPLN) Delisted Grant (A) +172,413 $0 EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.